Breast Cancer Clinical Trials

A listing of Breast Cancer medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 2378 clinical trials
Adjuvant Study of Pyrotinib in HER-2 Positive Breast Cancer (ATP)

positive breast cancer based on the 1-year trastuzumab standard adjuvant treatment with or without pertuzumab.

  • 0 views
  • 15 May, 2022
  • 1 location
ARX788 in HER2-positive, Metastatic Breast Cancer Subjects (ACE-Breast-03) (ACE-Breast03)

A Global, Phase 2 Study of ARX788 in HER2-positive, Metastatic Breast Cancer Patients whose Disease is Resistant or Refractory to T-DM1, and/or T-DXd, and/or Tucatinib-containing Regimens

  • 7 views
  • 03 Jul, 2022
  • 53 locations
  • 0 views
  • 09 Aug, 2022
  • 1 location
Anrotinib in Combination With Capecitabine in Advanced Triple Negative Breast Cancer

capecitabine combined with antinib in the treatment of recurrent or metastatic triple-negative breast cancer

  • 0 views
  • 24 Mar, 2022
  • 2 locations
Pilot Study of Cabazitaxel and Paclitaxel in HER2 Negative Breast Cancer

90 patients with HER2 negative breast cancer will be randomised to receive 18 weeks of chemotherapy treatment, either 6 cycles of 3 weekly Cabazitaxel or 6 cycles of weekly Paclitaxel to

  • 263 views
  • 23 Jan, 2021
  • 12 locations
Palbociclib Letrozole & Venetoclax in ER and BCL-2 Positive Breast Cancer

This study is investigating the combination of palbociclib, letrozole and venetoclax in ER and BCL-2 positive locally advanced or metastatic breast cancer. It is hypothesised that

measurable disease
metastatic carcinoma
carcinoma
local therapy
breast cancer
  • 45 views
  • 24 Jan, 2021
  • 3 locations
Neoadjuvant Endocrine Therapy Tolerance in Geriatric Early Stage ER+ Breast Cancer (POWER)

This single arm pilot study evaluates the use of pre-operative endocrine therapy in women with early stage ER+ breast cancer who are 65 years or older and are scheduled to have breast

aromatase inhibitor
tamoxifen
invasive breast cancer
anastrozole
hormone therapy
  • 1 views
  • 23 Apr, 2022
  • 1 location
Omic Technologies to Track Resistance to Palbociclib in Metastatic Breast Cancer

This is a monocentric cohort study, prospective and interventional with minimal risks and constraints for advanced breast cancer. The planned interventions are collection of biological samples

  • 0 views
  • 27 Jan, 2021
  • 1 location
Identification and Validation of Biomarkers for Breast Cancer Resistance Protein (BCRP) (BCRPmarker)

This is an open-label, non-randomized, fixed-sequence study. Subjects will undergo a rosuvastatin phase and eltrombopag and rosuvastatin phase to identify biomarkers for Breast Cancer Resistance

Accepts healthy volunteers
  • 0 views
  • 16 May, 2022
  • 1 location
CD40 Agonist, Flt3 Ligand, and Chemotherapy in Triple Negative Breast Cancer

, Doxil) are safe and effective at controlling the cancer in patients with metastatic triple negative breast cancer, and to determine a safe dose and treatment schedule of the three drugs. This research

  • 6 views
  • 13 Jul, 2022
  • 1 location